← Dashboard
Stock
BYAH
Park Ha Biological Technology Co., Ltd.0 of 27 marquee funds currently hold1 CUSIP mapped
Current holders
0
27 funds tracked
Ever held
2
Current + past
New this quarter
0
Exited this quarter
2
Marquee-fund ownership over time
Feb 14, 2025Feb 12, 2026May 14, 2026May 15, 2026
Now
0
This quarter's activity
New positions opened
None.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Citadel Advisors 2× in & out | Q1 2026 | Q2 2026 | — | +0% |
| Renaissance Technologies | Q1 2026 | Q2 2026 | — | +0% |
Fundamentals
XBRL · Park Ha Biological Technology Co., Ltd.Annual figures sourced directly from Park Ha Biological Technology Co., Ltd.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Revenue
$2.52M
FY2025+6% YoY
Net income
-$24.36M
FY2025-500%+ YoY
EPS (diluted)
$-41.38
FY2025-500%+ YoY
Free cash flow(?)
$85.85K
FY2025-91% YoY
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for Park Ha Biological Technology Co., Ltd. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 6-KREPORT OF FOREIGN PRIVATE ISSUERJun 4, 2026
- 20-F/AAMENDMENT NO. 2 TO FORM 20-FMay 15, 2026
- 20-F/AAMENDMENT NO. 1 TO FORM 20-FApr 29, 2026
- 6-KREPORT OF FOREIGN PRIVATE ISSUERMar 16, 2026
- 6-KREPORT OF FOREIGN PRIVATE ISSUERMar 6, 2026
- 20-FANNUAL REPORTMar 2, 2026
- 6-KREPORT OF FOREIGN PRIVATE ISSUERFeb 13, 2026
- 6-KREPORT OF FOREIGN PRIVATE ISSUERFeb 10, 2026
- 6-KREPORT OF FOREIGN PRIVATE ISSUERJan 28, 2026
- 6-KREPORT OF FOREIGN PRIVATE ISSUERDec 30, 2025
- 6-KCURRENT REPORTNov 28, 2025
- 6-KREPORT OF FOREIGN PRIVATE ISSUEROct 24, 2025
- 6-KREPORT OF FOREIGN PRIVATE ISSUEROct 8, 2025
- 6-KREPORT OF FOREIGN PRIVATE ISSUERSep 18, 2025
- 6-KREPORT OF FOREIGN PRIVATE ISSUERSep 5, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Citadel Advisors | Q1 2026 | Q2 2026 | $0.00 | — | +0% |
| Renaissance Technologies | Q1 2026 | Q2 2026 | $0.00 | — | +0% |
| Citadel Advisors | Q1 2025 | Q4 2025 | $0.00 | — | +0% |
Caveats
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.